Navigation Links
Nanobiotechnology - Global Strategic Business Report 2015-2022 - Demand for Novel Products to Push Up Growth - Research and Markets
Date:2/18/2017

DUBLIN, Feb 17, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Nanobiotechnology - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Nanobiotechnology in US$ Million.

Companies Profiled:

  • Ablynx NV (Belgium)
  • Arrowhead Pharmaceuticals, Inc. (USA)
  • Avadel Pharmaceuticals plc (Ireland)
  • CaPtivate Pharmaceuticals LLC (USA)
  • Celgene Corporation (USA)
  • ELITechGroup (France)
  • GlaxoSmithKline Plc. (UK)
  • Johnson & Johnson (USA)
  • Merck & Co., Inc. (USA)
  • NanoBio® Corporation (USA)
  • Nanophase Technologies Corporation (USA)
  • pSivida Corp. (USA)
  • Sigma-Aldrich Corp. (USA)
  • Starpharma Holdings Ltd. (Australia)
  • Vectura Group plc (UK) Key Topics Covered:

    1. INDUSTRY OVERVIEW

    2. COMPETITIVE SCENARIO

    3. MARKET DYNAMICS

Developing Countries to Rise over the Horizon

Nanomaterials & Nanoparticles Witness Robust Activity

Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials

Why Invest in Nanobiotechnology?

Private and Public Companies to Step Up Funding on Nanotechnology

United States Lead the Way in Government Funding

Increasing Awareness on Technology to Drive Growth

Demand for Novel Products to Push Up Growth

Nano-Enabled Drug Discovery Holds Tremendous Potential

Consolidation Sharpens the Industry's Edge

4. INDUSTRY CHALLENGES & ISSUES

5. INDUSTRY STRUCTURE

6. NANOBIO'S EPOCHAL STRIDES IN MODERN MEDICINE

7. INNOVATIONS & ADVANCEMENTS

8. CONCEPTUAL OVERVIEW

9. GLOBAL RESEARCH CENTERS AND INSTITUTIONS

10. RECENT INDUSTRY ACTIVITY

Vectura Group Inks Merger Agreement with Skyepharma Flamel Technologies to Merge with Avadel Pharmaceuticals

Pfizer to Acquire BIND Therapeutics Assets Janssen Sciences Ireland Enters into Collaboration with ViiV Healthcare

Tekna Holdings Canada Inks Agreement with National Research Council of Canada Roche and BioMed X Sign a Collaboration Agreement

Ablynx Enters into Exclusive Research Collaboration with Genzyme

Pfizer Exercises Option to Develop and Commercialize Accurin BIND Therapeutics Inks Joint Research and Development Agreement with Merck

11. FOCUS ON SELECT GLOBAL PLAYERS

12. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 79

The United States (49)

Canada (2)

Japan (1)

Europe (19)

- France (2)

- Germany (6)

- The United Kingdom (4)

- Rest of Europe (7)

Asia-Pacific (Excluding Japan) (5)

Middle East (3)

For more information about this report visit http://www.researchandmarkets.com/research/hdjs9m/nanobiotechnology

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nanobiotechnology---global-strategic-business-report-2015-2022---demand-for-novel-products-to-push-up-growth---research-and-markets-300409605.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Global Nanobiotechnology Report 2015-2025 - Focus on Applications, Markets and Companies with Profiles of 250+ Companies - Research and Markets
2. Global Nanobiotechnology Report 2016 - Applications, Markets and Companies Analysis to 2025 -- Research and Markets
3. Global Nanobiotechnology Report 2016-2025 - Profiles of 248 Companies with their 180 Collaborations
4. Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024
5. Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies
6. Global Nanobiotechnology Report 2015 - Applications, Markets and Companies Forecasts to 2024
7. MDNA Begins Global Roll-Out with Appointment of Distribution Partner in South Korea
8. Synthetic Biology: Global Markets - Research and Markets
9. Lexicon To Present At The Leerink Partners 6th Annual Global Healthcare Conference
10. Mirati Therapeutics To Present At Leerink Partners 6th Annual Global Healthcare Conference
11. Protein Labeling Market is Expected to Reach $5,350 million by 2022, Globally-Allied Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2018)... ... August 28, 2018 , ... Cognition Corporation ®, a software company ... for NAVIGATE2018 . , Ryan Ward, Director of Engineering at Zimmer Biomet, ... An experienced engineer and manager with Zimmer Biomet for almost 15 years, Mr. Ward ...
(Date:8/29/2018)... ... August 28, 2018 , ... USDM Life Sciences , the leading ... healthcare industries, announces that Manu Vohra will deliver a presentation at the BoxWorks ... to Implement Box for GxP in 30 Days” , When: Thursday, August 30, 1:00-1:50 ...
(Date:8/23/2018)... , ... August 23, 2018 , ... Visikol ... Co-Founder Dr. Thomas Villani. Through support from advisors, mentors, the Rutgers Technology Transfer team ... , Visikol’s path from an idea to a successful biotech company has been a ...
(Date:8/17/2018)... (PRWEB) , ... August 16, 2018 , ... ... organization (CRO) is pleased to announce the expansion of their team. Dr. Dawn ... hired to launch an innovative large molecule LC-MS/MS group that will specialize in ...
Breaking Biology Technology:
(Date:9/7/2018)... ... September 06, 2018 , ... Sensors Midwest ... show Sensors Expo & Conference , announces their partnership with Fraunhofer USA ... an IoT Enabled Industrial IoT Certification Program. Taking place on October 17, 2018 ...
(Date:8/31/2018)... ... August 30, 2018 , ... ... as a component of drug discovery programs. Longer-target engagement can result in improved ... low throughput, require expensive instrumentation, or require the alteration of the molecules involved. ...
(Date:8/29/2018)... (PRWEB) , ... August 28, ... ... a radiopharmaceutical company unlocking the full power of positron emission tomography (PET), ... metal catalysis, Fuzionaire Dx is helping clinicians and researchers study and cure ...
Breaking Biology News(10 mins):